| 摘要 |
The object of the present invention is to provide a ginsenoside composition which can obtain specific and excellent result in terms of efficacy, to various symptoms and diseases. The ginsenoside composition includes 3 components of Rb 1, Rg 3 (S), and Rg 2(S), which are ginsenosides, as an essential component. In solid base of the composition, the ginsenoside composition satisfies the following 3 requirements. That is, (Requirement 1): a content of the Rb 1 is 7.3 mg/g or more, (Requirement 2): a ratio of a content of the Rb 1 and a content of the Rg 3 (S), "Rb 1 / Rg 3 (S)", is in a range of 1.2 to 3.7, and (Requirement 3): a ratio of a content of the Rg 3 (S) and a content of the Rg 2 (S), "Rb 3 (S) / Rg 2 (S)", is in a range of 1.7 to 4.4. |
